Evidence map›Paper›PMID 39453872›Full record

ArticleAIDS (London, England)2025

Biomarkers of microbial translocation and generalized inflammation are associated with frailty among people with HIV.

Stephanie A Ruderman, Peter W Hunt, Gabriele Beck-Engeser, Gabrielle Ambayec, Amanda L Willig, Michael S Saag, Sonia Napravnik, Edward Cachay, Laura Bamford, Alan Landay and 8 more

Abstract read
In one paragraph

Article in AIDS (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Stephanie A RudermanDepartment of Medicine, University of Washington, Seattle, WA.
Peter W HuntDepartment of Medicine, University of California San Francisco, San Francisco, CA.
Gabriele Beck-EngeserDepartment of Medicine, University of California San Francisco, San Francisco, CA.
Gabrielle AmbayecDepartment of Medicine, University of California San Francisco, San Francisco, CA.
Amanda L WilligDepartment of Infectious Disease, University of Alabama at Birmingham, Birmingham, AL.
Michael S SaagDepartment of Infectious Disease, University of Alabama at Birmingham, Birmingham, AL.
Sonia NapravnikDivision of Infectious Disease, University of North Carolina, Chapel Hill, NC.
Edward CachayDepartment of Medicine, University of California San Diego, San Diego, CA.
Laura BamfordDepartment of Medicine, University of California San Diego, San Diego, CA.
Alan LandayDepartment of Internal Medicine, University of Texas Medical Branch Galveston, Galveston, TX, USA.
Lydia N DrumrightDepartment of Medicine, University of Washington, Seattle, WA.
L Sarah MixsonDepartment of Medicine, University of Washington, Seattle, WA.
Bridget M WhitneyDepartment of Medicine, University of Washington, Seattle, WA.
Robin M NanceDepartment of Medicine, University of Washington, Seattle, WA.
Mari M KitahataDepartment of Medicine, University of Washington, Seattle, WA.
Heidi M CraneDepartment of Medicine, University of Washington, Seattle, WA.
Joseph A C DelaneyDepartment of Medicine, University of Washington, Seattle, WA.
Andrew W HahnDepartment of Medicine, University of Washington, Seattle, WA.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patientsR01HL126538 · NHLBI · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., CROTHERS, KRISTINA ANNE · 2015 to 2025
$5.1M
HIV and Aging Research Consortium (HARC)R33AG067069 · NIA · UNIVERSITY OF WASHINGTON · PI STEVEN N. AUSTAD, Heidi M. Crane · 2020 to 2026
$4.8M
Assessing the Interrelationship Between Adipose Tissue Thermogenesis and Fibrosis in the Metabolic Health of People Living with HIVR01DK141041 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PETER W HUNT, SUNEIL Krishna KOLIWAD · 2024 to 2026
$2.3M
Persistent Functional Immune Defects in Treated HIV InfectionK24AI145806 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUNT, PETER W · 2020 to 2024
$921k
Plasma Proteomic and Metabolomic Predictors of Vascular Disease in Treated HIVR56HL160457 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUNT, PETER W · 2021 to 2021
$789k
NHLBI NIH HHS R01 HL126538NHLBI NIH HHS R56 HL160457NIAID NIH HHS K24 AI145806NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI027767NIAID NIH HHS R24 AI067039NIA NIH HHS R33 AG067069NIDDK NIH HHS R01 DK141041
6 · The paper itself

Abstract

backgroundFrailty occurs at higher rates and younger ages among people with HIV (PWH) compared with the general population and is often attributed to chronic inflammation and subsequent immune exhaustion. We assessed how inflammatory biomarkers are associated with frailty among PWH.

methodsThe Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) cohort is comprised of adult PWH in care at 10 sites, and harmonizes demographic, clinical, and patient-reported outcomes (PRO) data. A panel of 13 inflammatory biomarkers was collected from a subset of virally suppressed PWH once per person between 2010 and 2018. Frailty was measured with a validated PRO phenotype, scored 0-4, from biomarker collection date through July 2022. With adjusted linear mixed models, we estimated longitudinal associations between standard deviation-scaled log 2 -transformed biomarkers and frailty score.

resultsAmong 273 PWH, most were men (91%), average age at baseline was 45, 42% were non-Hispanic White whereas 35% were non-Hispanic Black, and average follow-up time was 5.5 years. Several biomarkers were associated with higher frailty, including those linked to microbial translocation (sCD14, LBP, KT ratio) and systemic inflammation (CRP, IL-6, suPAR, sTNFR1, sTNFR2). Higher IL-6 was associated with a 0.25-point higher frailty score [95% confidence interval (CI) 0.12-0.39]. Higher sTNFR1 [0.35 (0.13-0.56)], sCD14 [0.21 (0.11-0.31)], and suPAR [0.24 (0.11-0.36)] levels were also associated with higher frailty scores over follow-up.

conclusionHigher levels of biomarkers linked to microbial translocation and systemic inflammation are associated with higher average frailty scores over time in a cohort of virally suppressed PWH, highlighting these pathways as potential interventional targets for mitigating frailty in PWH.

Indexed as

Bacterial TranslocationBiomarkersFrailtyHIV InfectionsInflammationAdultCohort StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedBiomarkers

Identifiers

PMID39453872
PMCPMC11717601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.